[O2–14–02]: PRECLINICAL ASSESSMENT OF KAL‐ABP TARGET ENGAGEMENT AND EFFICACY USING PET, MRI AND CSF BIOMARKERS. (1st July 2017) - Kang, Min Su; Shin, Monica; Collins, Louis; Massarweh, Gassan; Soucy, Jean‐Paul; Brown, Leslie; Delaney, Christie; Pelletier, Alex; Haqqani, Arsalan; Durocher, Yves; Rennie, Kerry; Stanimirovic, Danica; et al.